tiprankstipranks
Trending News
More News >
Nath Bio-Genes (India) Ltd. (IN:NATHBIOGEN)
:NATHBIOGEN
India Market

Nath Bio-Genes (India) Ltd. (NATHBIOGEN) Financial Statements

Compare
3 Followers

Nath Bio-Genes (India) Ltd. Financial Overview

Nath Bio-Genes (India) Ltd.'s market cap is currently ₹2.87B. The company's EPS TTM is ₹2.535; its P/E ratio is 6.59; and it has a dividend yield of 1.26%. Nath Bio-Genes (India) Ltd. is scheduled to report earnings on November 13, 2025, and the estimated EPS forecast is ₹―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue₹ 3.65B₹ 2.48B₹ 3.01B₹ 2.78B₹ 3.07B
Gross Profit₹ 2.29B₹ 1.03B₹ 1.67B₹ 1.54B₹ 1.71B
Operating Income₹ 459.82M₹ 477.02M₹ 1.73B₹ 1.38B₹ 652.34M
EBITDA₹ 497.98M₹ 536.39M₹ 488.91M₹ -497.06M₹ 684.33M
Net Income₹ 386.00M₹ 396.19M₹ 350.11M₹ -673.38M₹ 556.62M
Balance Sheet
Cash & Short-Term Investments₹ 888.99M₹ 774.10M₹ 379.90M₹ 41.68M₹ 292.11M
Total Assets₹ 10.26B₹ 8.80B₹ 7.93B₹ 7.42B₹ 7.90B
Total Debt₹ 1.23B₹ 1.10B₹ 1.05B₹ 929.59M₹ 965.67M
Net Debt₹ 336.01M₹ 329.41M₹ 672.17M₹ 887.91M₹ 673.55M
Total Liabilities₹ 3.82B₹ 2.70B₹ 2.20B₹ 2.00B₹ 1.76B
Stockholders' Equity₹ 6.44B₹ 6.10B₹ 5.73B₹ 5.42B₹ 6.13B
Cash Flow
Free Cash Flow₹ 96.61M₹ 478.18M₹ 358.18M₹ -39.70M₹ -104.86M
Operating Cash Flow₹ 175.81M₹ 745.94M₹ 383.67M₹ 170.46M₹ 11.13M
Investing Cash Flow₹ -39.62M₹ -274.01M₹ -28.84M₹ -198.66M₹ -102.82M
Financing Cash Flow₹ -21.30M₹ -77.78M₹ -16.68M₹ -222.27M₹ 164.01M
Currency in INR

Nath Bio-Genes (India) Ltd. Earnings and Revenue History

Nath Bio-Genes (India) Ltd. Debt to Assets

Nath Bio-Genes (India) Ltd. Cash Flow

Nath Bio-Genes (India) Ltd. Forecast EPS vs Actual EPS